INTRODUCTION
Protein N-myristoylation refers to the co-translational covalent linkage of myristate, a 14-carbon saturated fatty acid (C14:0), to the N-terminal glycine of eukaryotic proteins. This protein modification appears to be irreversible and is catalysed by myristoylCoA : protein N-myristoyltransferase (Nmt). Nmt substrates have a variety of biological functions and include proteins involved in signal transduction pathways (kinases and their substrates, phosphatases, cc-subunits of heterotrimeric G proteins, N O synthase), vesicular trafficking within the Golgi apparatus (ADPribosylation factors, Arfs), as well as a number of structural and nonstructural proteins encoded by enveloped and nonenveloped viruses (reviewed by Johnson et al., 1994a; Chow & Moscufo, 1995) .
Several observations indicate that Nmt may be an attractive target for development of a new class of fungicidal agents for treating immunocompromised patients, including those with AIDS. Nmt is encoded by a single copy gene in Candida albicans and Cryptococcus neoformans (Wiegand et al., 1992; Lodge et al., 1994a) . Conditional lethal nmt alleles have been introduced into C. albicans and C. neoformans genomes by homologous recombination (Weinberg et al., 1995; Lodge et al., 1994b) . These alleles specify Nmts with reduced affinity for myristoyl-CoA owing to substitution of a conserved Gly, located five amino acids from their C-terminus, with an Asp. The mutant nmt alleles produce temperature-sensitive growth arrest and myristic acid auxotrophy. Withdrawal of myristate from the medium results in cell death, thereby establishing that Nmt is essential in these two organisms. In addition, an immunosuppressed rabbit model of human C. neoformans meningitis and an immunosuppressed mouse model of systemic C. albicans infection were used, together with isogenic strains of fungi with either wildtype or the conditional lethal nmt allele, to demonstrate that (genetic) attenuation of Nmt activity allows the immunocompromised host to cure itself of the fungal infection (Lodge et at., 1994b; Weinberg et al., 1995) .
In addition to genetic proof for the concept that Nmt is a target for development of fungicidal drugs, selective species-specific Nmt inhibitors have been produced (Devadas et al., 1995 (Devadas et al., ,1996 . The enzyme has an ordered bi bi reaction mechanism Rocque et al., 1993; Bhatnagar et al., 1994) . It binds myristoyl-CoA forming a binary complex. Conforrnational changes associated with ligation result in generation of a functional peptide-binding site and formation of a ternary myristoyl-CoA : Nmt : peptide complex. Catalysis and product release then occur. The myristoyl-CoA-binding sites of purified human Nmt and the fungal Nmts are highly conserved, but their peptide-binding specificities are quite divergent (Lodge et al., 199413; Devadas et al., 1995) . Starting with a highaffinity octapeptide substrate of C . albicans Nmt, dipeptide inhibitors of the fungal enzyme have been synthesized that are competitive for binding of peptide substrates but not myristoyl-CoA. Several potent inhibitors (Ki 30-60 nM) are selective (up to 400-fold) for the Candida enzyme compared to the human enzyme in uitro (Devadas et al., 1995 (Devadas et al., , 1996 The effects of members of this class of inhibitors on fungal growth and viability have not been reported. In this work, we describe development of an in viuo assay for protein N-myristoylation in C. albicans and its use in assessing the efficacy of Nmt inhibitors.
METHODS

Strains and media. Saccharomyces cerevisiae strains YB332
( N M T Z ) and YB336 (nmtZ-45ZD) are isogenic (Johnson et al., 199413) . S. cerevisiae strains TT104 (NMTZ arfZA: : HIS3 ARF2; Kahn et al., 1995) and TT139 ( N M T I ARFZ arf2A::LEUZ) are also isogenic and were obtained from Richard Kahn (Emory University, Atlanta, GA, USA). The methods used to construct the isogenic C. albicans strains MONCAlO5 ( N M T l n m t A ) and MONCA106 (nmt447D/nmtA) are detailed in Weinberg et al. (1995) . C. albicans strain B311 ( N M T / N M T ) is a previously characterized clinical isolate, obtained from George Kobayashi (Washington University, USA), which was used to isolate the fungus' N M T as well as one of its ARF genes (Wiegand et al., 1992; Langner et al., 1992) .
(w/v) peptone (Difco) and 2% (w/v) dextrose. YPD/ myristate contained 500 pM myristate (Nuchek Prep) and 1 % Brij-58 (Sigma). Yeast Nitrogen Base broth (YNB) was obtained from Difco. (Barnes, 1994) plus the following cycling conditions: 94 'C for 15 s, 55 "C for 30 s, 72 "C for 5 min, repeated 25 times. PCR fragments were purified by agarose gel elecrrophoresis and transformed (Gietz et al., 1995) into YB332 and YB336. The resulting strains, YB535 (NMTZ arflA: :HIS3 ARFZ), : HIS3 ARF2), YB537 (NMTZ ARFl arf2A::LEUZ) and YB541 (nmtl-45lD ARFl arf2A : : LEU2), were prototrophic for either histidine or leucine. Replacement of their wild-type ARFI or ARF2 genes with the corresponding arf null alleles was confirmed by PCR using the primers listed above. Generation of N-myristoylated and nonmyristoylated Arf standards. A dual plasmid expression system was used to produce N-myristoylated S. cerevisiae Arflp or Arf2p in Escherichia coli strain JMlOl (Lodge et al., 1994a) . This system consists of two recombinant plasmids with N M T l or ARF inserts under the control of different inducible promoters. Nmtlp expression is initiated in exponentially growing bacteria followed 30 min later by induction of an Arf substrate. The corresponding nonmyristoylated Arfs were obtained by simply omitting the expression vector encoding Nmtlp (note that E. coli has no endogenous Nmt activity). Bacterial lysates were prepared (Lodge et al., 1994a) and used as standards for a protein mobility gel shift assay described below. A similar strategy was used to produce Nmyristoylated and nonmyristoylated forms of a C. albicans Arf originally cloned from strain B311 .
Construction of
A protein mobility assay for examining cellular levels of Nmyristoylated and nonmyristoylated Arf proteins.
arflA ARF2) and YB541 (nmtl-45lD ARFl arf2A), or C. albicans strains MONCAlO5 (NMT/nmtA) and MONCAlO6 (nmt447D/nmtA), were grown overnight at a permissive temperature in YPD/myristate to an OD,,, x 2-0-3.0 (measured with an KB Ultrospec I1 spectrophotometer). Cells were collected by centrifugation at room temperature. Each cell pellet was washed three times with 25 ml PBS (0.145 M NaCl; 0-15 M sodium phosphate, pH 7.4), and resuspended in 4-6 ml YPD. A 1 ml aliquot was added to 10 ml YPD or YPD/myristate and incubated at 24, 30 or 37 "C for 2 or 4 h. Cells were then pelleted as above, washed once in 5 ml PBS, and resuspended in 0.5 ml lysis buffer (4 ' / o , w/v, SDS; 0.125 M Tris/HCl, pH 6.8). An equal volume of glass beads (425-600 pm diameter; Sigma) was added, and the suspension was vortexed for 1 min alternating with ice for 1 min for a total of three cycles. The lysates were then boiled for 5 min and cellular debris was removed by centrifugation at 10000 g for 10 min. The protein concentrations of the resulting supernatants were determined with the BCA kit (Pierce). (w/v) sodium azide (Sigma). Arflp was detected in S. cerevisiae lysates using rabbit antiserum R23, which was raised against a peptide encompassing the C-terminal eight residues of the protein (SNSLKNST'"). Arf2p was identified with rabbit antiserum R29 generated using an S. cerevisiae Arf2p C-terminal peptide (SNNLKNQS'"). Both antisera were supplied by R. Kahn and were employed at a final dilution of 1 :2OOOO (for S. cerevisiae lysates) or 1:4000 (for C. albicans lysates) in blocking buffer. All Arf mobility assays were repeated at least three times using independently derived cell lysates.
Characterization of dipeptide inhibitors of C. albicans Nmt
Determination of IC,, for C. albicans and human Nmts in vitro. Synthesis of the dipeptide Nmt inhibitor SC-58272 is described in an earlier report (compound 17 in Devadas et al., 1995) . Details concerning syntheses of SC-59383 and its enantiomer SC-59840 will be published elsewhere. The purified compounds exhibited spectral and analytical data consistent with the structures shown. IC,, values were calculated using (i) C. albicans B311 and human Nmts that had been produced in E. coli and purified to apparent homogeneity according to previously described protocols (Wiegand et al., 1992; Rudnick et al., 1992) , and (ii) a radiochemical HPLC end-point assay (Rudnick et al., 1992; Devadas et al., 1995) . The Nmt assay mixture (final volume 60 pl) contained variable amounts of the peptidomimetic inhibitor, 0.11 nmol [3H]myristoyl-CoA [l pCi (37 kBq); 9 Ci mmol-' (333 GBq mmol-')I, a substrate peptide (GNAASARR-NH, ; 2.2 nmol when using C. albicans Nmt, 0.22 nmol with the orthologous human N-myristoyltransferase), Nmt (10 and 75 ng of the purified E. coli-derived fungal and human enzymes, respectively), 0.2 M HEPES (pH 7.4), 2 mM DTT and 0.2 mM EDTA. Note that inhibitors were prepared in DMSO and the final concentration of DMSO in each assay was 0.5 Yo (v/v). All assays were performed on at least three occasions, each time in duplicate. Results are presented as mean values f 1 SD.
Determination of EC, , values of Nmt inhibitors.
Peptidomimetic inhibitors were prepared as 20 mM stock solutions in DMSO and diluted into sterile deionized water (DMSO concentration = 1 ' / o , v/v) to yield 2 x the final desired concentration for the culture-based assay. Portions (100 pl) of the 2 x stocks were dispensed into triplicate wells of a 96-well microtitre plate (Costar). C. albicans strain B311 (a 100 pl portion containing lo5 cells in 2 x YNB) was distributed into each of the wells.
Controls included DMSO alone (final concentration
negative control) and amphotericin B (final concentration = 0.05, 1 and 5 pg ml-'; positive control). Plates were incubated at 30°C and growth was scored by monitoring the OD,,, using an ELISA plate reader (Dynatech). EC,,, the concentration of compound inhibiting growth by 50 compared to untreated controls, was calculated at 24 and 48 h. All experiments were done in triplicate on at least three occasions. Within a given experiment, the triplicate determinations varied by < 10% per sample per time-point.
RESULTS
Defining the levels of N-myristoylation of cellular Arfs in 5. cerevisiae strains with wild-type and mutant NMTl alleles Temperature-sensitive mutants of NMTZ have proven to be valuable tools for studying the regulation of protein N-myristoylation in S. cerevisiae (Duronio et al., 1991; Johnson et al., 1993 Johnson et al., , 1994b . As in C. albicans, substitution of an Asp for the conserved Glyg51 located five residues from the C-terminus of the enzyme causes a temperature-sensitive reduction in the affinity of nmt451Dp for myristoyl-CoA. This is associated with global defects in cellular protein N-myristoylation (Duronio et al., 1991) . T h e S. cerevisiae nmtl-451D strain has no growth defects on rich media at 24 "C.
Growth arrest occurs within 1 h after shifting to 30-37 "C. Cells remain viable at 37 "C for 8 h. Death begins within 12 h, and no viable cells are detectable after 24 h (Johnson et al., 1994b) . Steady state levels of Nmtlp and nmt451Dp are comparable in isogenic strains 1 and 4 h after shifting to 37 "C (Johnson et al., 199413) .
Isogenic N M T l and nmtl-45ZD strains were used to develop an assay for assessing levels of cellular protein N-myristoylation. S. cerevisiae contains two principal Arf proteins, Arflp and Arf2p. These proteins are both N-myristoylated, require myristate for expression of their essential biological function(s), and are interchangeable (Stearns et al., 1990; Kahn et al., 1995; Randazzo & Kahn, 1995) . We had previously noted that N-myristoylation of Arflp or Arf2p changes their electrophoretic mobility during SDS-PAGE : myristoylArfp, produced in E. coli containing expression vectors encoding Nmtlp and one of the Arfs, migrates slightly faster during SDS-PAGE than nonmyristoylated Arf l p produced in bacteria containing only the Arfp expression vector (Lodge et al., 1994a) . This protein mobility gel shift formed the basis for monitoring protein N-myristoylation in nmtl-4.51 D cells during incubation at permissive and nonpermissive temperatures.
Although Arflp and Arf2p are 96% identical, the Ctermini are not well conserved. A rabbit antiserum raised against a peptide representing the C-terminus of Arflp (SNSLKNST) detects Arflp produced in E. coli but not E. coli-derived Arf2p (Fig. 1) . Similarly, a rabbit antiserum generated against the C-terminal eight residues of Arf2p (SNNLKNQS) recognizes Arf2p but not Arflp (Fig. 1) . Western blots of bacterial lysates demonstrated that each antibody preparation recognizes the N-myristoylated and nonmyristoylated forms of the corresponding recombinant Arf protein (Figs 1 and 2 ).
S. cereuisiae contains a third ARF gene encoding an Nmtlp substrate (Lee et al., 1994) . The specificity of the Arflp-and Arf2p-peptide-specific antibodies was further substantiated using a panel of isogenic S. cereuisiae N M T l strains with wild-type and null alleles of either ARFl or ARF2. The Arflp peptide antibodies do not recognize any proteins in Western blots of lysates prepared from NMTZ arfl A ARF2 ARF3 cells harvested during exponential growth in YPD (Fig. 1) . Likewise, the Arf2p peptide antibodies do not recognize any proteins in lysates prepared from isogenic NMTZ ARFl arf2A ARF3 cells incubated under the same conditions (Fig. 1) .
The Arf-specific antibodies were subsequently used to compare the state of Arflp and Arf2p N-myristoylation in isogenic strains containing all possible combinations of N M T l , nmt2-4SlD, A R F l , arflA, ARF2 and arf2A alleles. In N M T l strains, only a single Arflp or Arf2p species was observed during the mid-exponential phase of growth in YPD at 24,30 or 37 "C ( Fig. 2 and data not  shown) . The immunoreactive bands detected in protein blots of S. cereuisiae cell lysates co-migrated with E. coliderived N-myristoylated Arflp or N-myristoylated Arf2p standards (Fig. 2 and data not shown) . These findings indicate that both Arflp and Arf2p are fully myristoylated in N M T l cells under these growth conditions.
The nmtl-45ZD ARFl ARF2 strain was also grown to mid-exponential phase at the permissive temperature and then incubated for an additional 2 h at 24, 30 or 37 "C in YPD or YPD/myristate. In the presence of YPD/myristate, there was a progressive increase in the amount of nonmyristoylated Arflp or Arf2p species as the temperature was raised from 24 to 37 "C, although the percentage did not exceed SO?" of total cellular Arflp or total Arf2p (Fig. 2) . In the absence of myristate, nonmyristoylated Arflp and Arf2p reached 50% of the total at the temperature where cells underwent growth arrest (see lanes marked 37 "C in Fig. 2 ). Note that two criteria were used to identify the nonmyristoylated forms of Arflp and Arf2p: (i) their reaction with peptide-specific antibodies ; and (ii) their co-migration with the recombinant nonmyristoylated Arflp and Arf2p, which themselves have distinct mobilities.
Similar experiments using isogenic nmtl-45lD strains with arfZA or arf2A null alleles and the Arf-peptidespecific antibodies confirmed that there is an equivalent increase in the fractional representation of nonmyristoylated Arflp and Arf2p as the temperature is increased. Moreover, supplementation of the medium with myristate produces a comparable 'return ' of the Nmyristoylated forms of both Arfs (Fig. 2 plus data . One ARF gene has been recovered from this organism Denich et al., 1992) . Expression of its protein product, with or without C. albicans Nmt, in E. coli cells confirmed that this Arf is a substrate for the N-myristoyltransferase and that covalent attachment of myristate produces an increase in its mobility on SDS-PAGE (Lodge et al., 1994a The S. cerevisiae Arflp-peptide-specific antiserum recognizes a -20 kDa protein produced in the NMT/ n m t A strain of C. albicans (Fig. 3) . This protein has the same mobility on SDS-PAGE as (i) the Arf(s) which are metabolically labelled in the fungus by Western blots established that the Arflp-peptide-specific antibodies do not react with the C. albicans Arf produced in E. coli, whether or not it contains an Nterminal myristoyl moiety (data not shown). Moreover, the C-termini of the S. cerevisiae Arflp and the cloned C. albicans Arf are quite divergent (Arflp = SNSLKNST ; C. albicans Arf = SNQVGK). These findings suggest that Arflp-peptide-specific antiserum recognizes a protein encoded by another C. albicans ARF gene.
N M T l n m t A and n m t 4 4 7 D l n m t A strains of C. albicans
were grown in YPD/myristate at 24 "C to mid-exponential phase. Cells were then transferred to YPD with or without 500 pM myristate and incubated at 24 or 37 "C for an additional 2 or 4 h. Western blots of cell lysates were probed with the Arflp-peptide-specific antiserum. A single immunoreactive species was identified in N M T l n m t A cells under all growth conditions and at both time-points (Fig. 3 and data not  shown) . In contrast, a second, more slowly migrating immunoreactive protein species appeared in lysates prepared from n m t 4 4 7 D l n m t A cells. In the presence of myristate, this second, slowly migrating species was less abundant than the more rapidly migrating protein that co-migrated with the single band present in N M T l n r n t A Fig. 4 . Structures, and in vitro and in vivo activities of peptidomimetic compounds. I C, , values were determined using purified E. coli-derived human and C. albicans (strain B311) Nmts (HNmt and CaNmt, respectively). Selectivity refers to the ratio of the I C, , for the fungal :human enzyme. EC, , values were determined a t 24 and 48 h after administration of single doses of the compound to exponential-phase cultures of C. albicans strain B311.
cells. The fractional representation of the more slowly migrating species increases with increasing temperature (Fig. 3 ) . In the absence of myristate, the more slowly migrating irnmunoreactive protein becomes predominant, increasing within 2 h to > 50% at 24 "C and -90 */ o of the total at 37 "C (Fig. 3) . Comparable values were noted 4 h after withdrawal of myristate (data not shown). It is important to note that nmt447DlnmtA cells require supplementation of YPD with myristate for growth at 24 "C and begin to die within 4 h after removal of myristate (Weinberg et al., 1995) .
Based on these results, we concluded that a temperaturedependent increase in the more slowly migrating protein reflected an increase in the fractional representation of nonmyristoylated Arf. Attenuation of Nmt activity to the point where 2 50% of an Arf species is nonmyristoylated appears to be associated with growth arrest and loss of viability. enzyme. Substitution of Ala for Glyl yielded the competitive inhibitor ALYASKLS-NH,. Amino acids 1-4 were then replaced with a para-(2-methylimidazole-N-butyl) phenylacetic acid derivative, amino acids 7 and 8 (Leu-Ser-NH,) were deleted, and the 2-cyclohexylethyl amide derivative of lysine was used as the C-terminal residue. The structure of the resulting dipeptide inhibitor containing L-serine and L-lysine is presented in Fig. 4 as SC-58272 (cf. Devadas et al., 1995) . SC-58272 is a potent inhibitor of purified C. albicans Nmt with an IC,, of 56 nM. It is competitive for binding of peptide substrates but not myristoyl-CoA (Devadas et al., 1995) and 250-fold selective for the fungal enzyme compared to human enzyme (see Fig. 4 ). However, SC-58272 has no growth inhibitory effects on C. albicans cultured in YNB medium (EC,, > 100 pM) (Fig. 4) . N M T l n m t A cells were exposed for 2 or 4 h to 200 pM SC-58272 during exponential-phase growth. The Arf protein gel shift assay revealed no effect on Arf N-myristoylation (Fig. 5 ) . These findings suggest that SC-58272 is either metabolically unstable or does not gain access to Nmt within cells. Introduction of a carboxyl group geminal to the lysine amide nitrogen in SC-58272 yielded a tripeptide inhibitor containing L-serine, L-lysine and a cyclohexyl-L-alanine at its C-terminus (SC-59383 in Fig. 4 ). This compound is a less potent inhibitor of C. albicans Nmt than SC-58272 (IC50 1.45 k 0.08 pM) but is more selective for the fungal enzyme compared to human enzyme (560-fold versus 250-fold for SC-58272; see Fig. 4 ). Despite its more modest inhibitory activity in vitro, a single dose of 100 pM SC-59383 produced marked suppression of growth for 24 h (Fig. 6a) (EC,, 51 k 17 pM; Fig. 4 ). The effect was fungistatic rather than fungicidal. The effectiveness of a single dose of the compound diminishes with time (Fig. 6a) . Addition of 100 pM doses of the compound at 12 h intervals produced a sustained suppression of growth but not cell death (Fig. 6b) . The Arf protein gel shift assay indicated that a single dose of 200 pM of the compound produces a modest reduction in Arf N-myristoylation within 2 -4 h (Fig. 5 ) .
Further evidence that the fungistatic effect of SC-59383 is due to its Nmt inhibitory activity comes from an analysis of its enantiomer, SC-59840. Unlike SC-59383, SC-59840 contains D-Serine, D-lySine and a C-terminal cyclohexyl-malanine. Substitution of these D-for Lamino acids abolishes Nmt inhibitory activity in vitro (IC50 > 1000 pM), providing the first demonstration of the preference of C. albicans Nmt for L-amino acids at these positions. SC-59840 has no effect on cell growth (EC,, > 100 pM at 24 and 48 h; Figs 4 and 6b), even at concentrations up to 1000 pM (Fig. 6c) . Moreover, addition of a 200 pM dose of SC-59840 to N M T l n m t A cells produces no detectable inhibition of Arf Nmyristoylation (Fig. 5 ) .
DISCUSSION
The results presented above indicate that it is possible to monitor the state of cellular protein N-myristoylation in fungi using a simple assay based on differences in the mobilities of myristoylated and nonmyristoylated forms of Arfs. This protein mobility shift assay was used to help establish that inhibition of C. albicans Nmt by a competitive tripeptide inhibitor produces growth arrest. Such a finding provides further support for the notion that Nmt is an attractive target for fungistatic and possibly fungicidal therapy.
Although the structural basis for the different mobilities of N-myristoylated and nonmyristoylated Arfs during SDS-PAGE is unknown, it is not unprecedented. analogous to that shown in (a) except that a 100 pM dose of each compound was administered every 12 h (control, 0, = equivalent amount of DMSO vehicle). Aliquots were removed a t the various time-points and c.f.u. ml-' was determined under permissive growth conditions. The results indicated that SC-59383 had a fungistatic but no detectable fungicidal effect. Symbols are as in (a). (c) Dose-response curve for the peptidomimetics. A single dose of drug at the indicated concentration was added to exponential-phase cultures of strain B311 and the OD, , , was measured 24 h later. Note that SC-59840 has no effect on growth a t 1000 pM, which is a t the limit of its solubility. A, 0 , protein involved in the mating factor signal transduction cascade of S. cerevisiae. Dohlman et al. (1993) reported that a-factor treatment of MATa strains promotes replacement of a pool of nonmyristoylated Gpalp with newly synthesized myristoyl-Gpalp and suggested that this represents a mechanism for long-term regulation of the mating factor signalling pathway. Like the nonmyristoylated form of Arf, the nonmyristoylated form of Gpalp has a slower mobility during SDS-PAGE than the N-myristoylated species. Protein N-myristoylation is a co-translational modification (reviewed in Johnson et al., 1994a) . Gpalp is the only S. cereuisiae N-myristoylated protein that is detectable in both N-myristoylated and nonmyristoylated forms in cells with a wild-type NMTZ allele. The studies of Dohlman and co-workers (1993) indicated that both forms of Gpalp are rapidly degraded, that they both need continuous protein synthesis to be maintained, and that the nonmyristoylated species was not generated by demyristoylation of N-myristoylated Gpalp. Although the mechanism is not known, it appears that the Gpalp produced after a-factor treatment of MATa NMTI cells is more efficiently N-myristoylated. Unlike the case of Gpalp, the mechanism underlying the appearance of nonmyristoylated Arfs appears to be directly attributable to a reduction in Nmt activity. In cells with wild-type NMT alleles, Arfs are fully Nmyristoylated, i.e. this substrate for Nmt does not 'escape ' covalent N-myristoylation. When Nmt activity is diminished, either through genetic or pharmacological manipulations, an ' escape ' from N-myristoylation is observed. The escape increases in a progressive fashion as the temperature-sensitive Nmt mutant is subjected to higher incubation temperatures. Escape can be suppressed when this mutant temperature-sensitive Nmt with reduced affinity for myristoyl-CoA is exposed to augmented cellular myristoyl-CoA pools. Thus, several factors make the Arf proteins very attractive reporters for monitoring cellular Nmt activity. They are fully Nmyristoylated in cells with fully active Nmt (i.e. the baseline appears to be 100 % N-myristoylation). Their gel mobility shifts are readily detected because they are small proteins and both N-myristoylated and nonmyristoylated forms have similar reactivity to antibodies. Finally, because Arfs are ubiquitous proteins that are highly conserved throughout evolution, we anticipate that the mobility shift assay can be applied to a wide variety of organisms.
As noted in the Introduction, Arflp and Arf2p are interchangeable proteins that need myristate to fulfill their essential functions. In S . cereuisiae, Arflp is the predominant cellular Arf, accounting for -90 % of total cellular Arfs (Stearns et al., 1990) . Although the loss of N-myristoylated forms of Arfs is a marker of growth arrest, several observations suggest that it is unlikely to be the only N-myristoylprotein whose loss contributes to the demise of cells. Overexpression of ARFI is not sufficient to rescue nmtl-45ZD cells (Johnson et a!., 1993) . NMTZ arf2A ARF2 cells are viable even though their levels of Arfs are -10% those in isogenic ARFZ ARF2 cells. An nmtZ-452D ARFI ARF2 cell has more N-myristoylated Arflp/Arf2p 2 4 h after growth arrest than does a proliferating N M T I arfZA ARF2 cell (i.e. 50% compared to 10% of levels encountered in a wild-type NMTZ ARFZ ARF2 cell). Finally, S. cereuisiae contains other N-myristoylproteins such as Gpalp which are essential and which require myristate for their function.
Monitoring protein N-myristoylation in vivo
In C. albicans, a 2 50% reduction in N-myristoylated Arf appears to be a marker of an unviable cell. Genetic or pharmacological manipulations of Nmt activity that reduce the fractional representation of N-myristoylated Arfs to this value would be expected to have a fungicidal effect. Other N-myristoylproteins are known to be produced by this organism, including a homologue of Gpalp encoded by the CAGl gene (Sadhu et al., 1992) .
However, there are no published genetic or biochemical studies about whether the fungal Arfs or the Gpalp homologue are essential and/or dependent upon myristate for function.
We were able to conclude that the fungistatic effects of SC-59383 are directly related to its inhibition of cellular Nmt. This conclusion is based, in part, on the effects of the active tripeptide inhibitor of C. albicans Nmt (SC-59383) on Arf N-myristoylation and growth. Equally important was the fact that its enantiomer, SC-59840, had no effect on Nmt activity in vitro, on growth of C. albicans in culture, or on Arf N-myristoylation in vivo.
Together, these findings indicated that the fungistatic activity of SC-59383 is not due to a 'non-specific' physical (nonenzymic) effect on the organism (e.g. a detergent effect).
The inhibition of Arf N-myristoylation produced by SC-59383 is modest and well below the value of 50% associated with lethality. Such a modest reduction is consistent with its fungistatic rather than fungicidal effect. The biological effects of SC-59383 may be limited by its susceptibility to degradation by cellular carboxypeptidases : although prolonged incubation of the compound with media harvested from C. albicans cultures produces no degradation, addition of cell lysates results in removal of the C-terminal cyclohexyl-L-alanine or this residue and L-lysine (data not shown). Repeated additions of SC-59383 to cultures produces a more prolonged growth suppressive effect, consistent with the notion that the compound has limited stability within cells, It will be interesting to examine the effects of modifications in SC-59383 that make it less susceptible to carboxypeptidase digestion : greater stability may allow a related compound to produce a more pronounced inhibition of cellular protein N-myristoylation and a fungicidal effect.
Finally, it is important to note that SC-59383 retains the Ser-Lys dipeptide critical for recognition of natural substrate proteins by fungal Nmts (reviewed in Johnson et al., 1994a) . Thus, it appears unlikely that C. albicans Nmt will be able to acquire mutations that would allow it to escape the growth arrest produced by Ser-Lyscontaining peptidomimetic inhibitors without compromising the ability of this essential enzyme to fulfill its function in vivo.
